Schlusskurs
Andere Börsenplätze
|
||
- USD | - |
Kurzporträt
Manager
Manager | Titel | Alter | Seit |
---|---|---|---|
Remi Barbier
CEO | Chief Executive Officer | 64 | 01.05.98 |
Eric Schoen
DFI | Director of Finance/CFO | 55 | 01.10.18 |
James Kupiec
CTO | Chief Tech/Sci/R&D Officer | - | 04.01.21 |
Michael Zamloot
CTO | Chief Tech/Sci/R&D Officer | - | - |
Chief Tech/Sci/R&D Officer | - | - | |
Director/Board Member | 65 | 01.06.98 | |
Robert Cook
LAW | General Counsel | 60 | 01.10.22 |
Michael Marsman
LAW | General Counsel | - | - |
Aufsichtsräte
Aufsichtsräte | Titel | Alter | Seit |
---|---|---|---|
Remi Barbier
CEO | Chief Executive Officer | 64 | 01.05.98 |
Robert Gussin
BRD | Director/Board Member | 86 | 01.03.03 |
Patrick Scannon
BRD | Director/Board Member | 76 | 07.12.07 |
Director/Board Member | 92 | 01.09.98 | |
Richard Barry
BRD | Director/Board Member | 65 | 11.06.21 |
Director/Board Member | 65 | 01.06.98 | |
Claude Nicaise
BRD | Director/Board Member | 71 | 07.12. |
Robert Anderson
BRD | Director/Board Member | 58 | 07.12. |
Pierre Gravier
BRD | Director/Board Member | 39 | 07.12. |
Anteilsklasse
Vote | Menge | Streubesitz | Konzerneigene Aktien | Total Float | |
---|---|---|---|---|---|
Aktie A | 1 | 43 245 758 | 40 072 808 ( 92,66 %) | 0 | 92,66 % |
Unternehmenskontakt
Cassava Sciences, Inc.
6801 North Capital of Texas Highway Suite 300
78731, Austin
+512 501 2444
http://www.cassavasciences.comSektor
% 1. Jan. | Kap. | |
---|---|---|
+2.93% | 106 Mrd. | |
+7.02% | 23.47 Mrd. | |
-14.60% | 21.9 Mrd. | |
-7.05% | 18.77 Mrd. | |
-38.55% | 17.85 Mrd. | |
-8.83% | 16.78 Mrd. | |
+5.51% | 14.41 Mrd. | |
+37.49% | 12.86 Mrd. | |
+329.39% | 8.78 Mrd. |
- Börse
- Aktien
- A2PGL8 Aktie
- Aktie
- Unternehmen Pain Therapeutics, Inc.